miR-185 Inhibits Hepatocellular Carcinoma Growth by Targeting the DNMT1/PTEN/Akt Pathway
2014 · American Journal Of Pathology · 100 citations
https://doi.org/10.1016/j.ajpath.2014.05.004
J
Jinqiang Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
1.2K
Citations
17
h-index
23
i10-index
Jinqiang Zhang is an academic researcher. The author has contributed to research in topics: RNA modifications and cancer & Epigenetics and DNA Methylation & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 17, co-authored 60 publications.
ORCID: 0000-0001-9594-276XPapers by this author
works<i>ABCC4</i>copy number variation is associated with susceptibility to esophageal squamous cell carcinoma
2014 · Carcinogenesis · 55 citations
https://doi.org/10.1093/carcin/bgu043
Immunometabolic modulation of retinal inflammation by CD36 ligand
2019 · Scientific Reports · 26 citations
https://doi.org/10.1038/s41598-019-49472-8
Deletion of Mir155 Prevents Fas-Induced Liver Injury through Up-Regulation of Mcl-1
2015 · American Journal Of Pathology · 22 citations
https://doi.org/10.1016/j.ajpath.2014.12.020
Are Capecitabine and the Active Metabolite 5-FU CNS Penetrable to Treat Breast Cancer Brain Metastasis?
2014 · Drug Metabolism and Disposition · 20 citations
https://doi.org/10.1124/dmd.114.061820
BC-15 binds to various kinds of human cancer cells.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0121920.g001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat